Elegent, a UGent spin-off company, is a dynamic modelling consultancy firm, dedicated to optimizing pharmaceutical development processes. Within the CESPE consortium, we bring invaluable expertise in data-driven and physics-based pharmaceutical engineering. Their focus is accelerating drug product production of solid oral dosages via continuous direct compression and wet granulation through advanced modelling techniques. With a commitment to sustainability and innovation, Elegent complements the consortium’s mission to revolutionize pharmaceutical manufacturing.
The expertise at Elegent centres on bridging the gap between academic innovations and practical applications in pharmaceutical engineering. Within the CESPE consortium, their specialization is utilizing quantitative data-driven support for drug product development. They excel in custom process modelling, formulation, process development, and process analytical technology (PAT) implementation. By leveraging their extensive knowledge in pharmaceutical technology and data science, they help CESPE and its industrial partners drive sustainable innovation, enabling efficient pharmaceutical care delivery to patients.